Breaking News Instant updates and real-time market news.

DIS

Disney

$106.03

1.26 (1.20%)

06:26
07/10/18
07/10
06:26
07/10/18
06:26

Disney to develop new Manhattan campus downtown for $650M, WSJ reports

Disney is selling its uptown Manhattan campus to develop a new downtown campus for $650M, according to the Wall Street Journal. Disney sold the Upper West Side offices for $1.155B and will lease it back while the new offices are built. Development is in the early stages and the new building, which will contain roughly 1M square feet, will be erected on a full city block. Reference Link

DIS Disney
$106.03

1.26 (1.20%)

06/28/18
IMPC
06/28/18
INITIATION
Target $108
IMPC
In-Line
Disney initiated with an In-Line at Imperial Capital
Imperial Capital analyst David Miller started Disney with an In-Line rating and $108 price target. Disney's largest business, Media Networks, is struggling, while its three other units, Parks/Resorts, Consumer Products/Interactive, and the Studio are operating at a "truly best-in-class manner," Miller tells investors in a research note. The analyst would wait for a "measurable pullback" before becoming more constructive on the shares.
07/03/18
IMPC
07/03/18
NO CHANGE
Target $32
IMPC
Outperform
Discovery will not bid for Fox regional sports networks, says Imperial Capital
Imperial Capital analyst David Miller says Discovery (DISCA) is seeing "unnecessary selling pressure" on media reports that the company is a potential bidder for the Fox regional sports networks, which Disney (DIS), through its pending acquisition of the entertainment assets of 21st Century Fox (FOXA), will have to divest, as per the Department of Justice decree. The analyst believes potential bidders for these assets will include Charter (CHTR), Liberty Media (LMCA), Altice (ATUS), and various private equity entities, but not Discovery. Discovery is fully occupied with the integration of Scripps Networks, the sale of its headquarters building in Bethesda, Maryland, as well as ratings issues at its core Discovery Channel, Miller tells investors in a research note. Further, he notes that Discovery already pledged $2B in additional sports rights to broadcast various PGA Tour events via its networks outside of the U.S. through 2030. As such, the analyst thinks the recent pullback has created an "attractive opportunity to either establish new positions, or for existing holders to lower their bases." Miller keeps an Outperform rating on Discovery with a $32 price target.
07/05/18
RBCM
07/05/18
NO CHANGE
Target $135
RBCM
Top Pick
Disney entering 'transitional period' on Fox transaction, says RBC Capital
RBC Capital analyst Steven Cahall kept his Top Pick rating and $135 price target on Disney (DIS) but reduced his FY18 EPS view to $7.07 from $7.18 on the writedown of disappointing Solo film performance, 21st Century Fox (FOXA) transaction costs, and expectations of a smaller stock buyback. Despite the favorable trends in Media and Parks segments, Cahall says the company is now in a "transitional period" as it seeks to meet antitrust regulators' divestment requirements. The analyst notes that Disney stock will likely be range-bound "until the dust settles".
07/06/18
IMPC
07/06/18
NO CHANGE
Target $108
IMPC
In-Line
Imperial sees $70M opening for Disney's 'Ant-Man and The Wasp'
Disney's "Ant-Man and The Wasp" will be released today on around 6,300 screens beginning today, Imperial Capital analyst David Miller tells investors in a research note. Based on conversations with select contacts at the exhibitor level and previous Marvel-branded releases, the analyst estimates the film will open at $70M. He sees total domestic sales of $210M and total global sales of $585M. Miller maintains an In-Line rating on Disney with a $108 price target.

TODAY'S FREE FLY STORIES

AAPL

Apple

$219.28

3.3 (1.53%)

08:09
10/22/18
10/22
08:09
10/22/18
08:09
Recommendations
Apple analyst commentary  »

Apple iPhone pricing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZAYO

Zayo Group

$31.97

0.01 (0.03%)

08:09
10/22/18
10/22
08:09
10/22/18
08:09
Hot Stocks
Major retailer selects Zayo for nationwide network »

A major retailer has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

ARCE

Arco Platform

$22.91

-0.04 (-0.17%)

08:09
10/22/18
10/22
08:09
10/22/18
08:09
Initiation
Arco Platform initiated  »

Arco Platform initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBPH

Theravance Biopharma

$29.16

-0.14 (-0.48%)

08:08
10/22/18
10/22
08:08
10/22/18
08:08
Hot Stocks
Theravance Biopharma reports data from TD-1473 Phase 1b study »

Theravance Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 27

    Nov

  • 18

    Dec

TCF

TCF Financial

$22.45

-0.43 (-1.88%)

08:08
10/22/18
10/22
08:08
10/22/18
08:08
Earnings
TCF Financial reports Q3 EPS 51c, consensus 48c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 15

    Nov

BMRC

Bank of Marin

$79.52

0.41 (0.52%)

08:08
10/22/18
10/22
08:08
10/22/18
08:08
Earnings
Bank of Marin reports Q3 EPS $1.23, consensus $1.17 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

MLNT

Melinta Therapeutics

$3.79

-0.01 (-0.26%)

, AVEO

Aveo Pharmaceuticals

$2.50

-0.03 (-1.19%)

08:07
10/22/18
10/22
08:07
10/22/18
08:07
Hot Stocks
Melinta Therapeutics CEO Dan Wechsler steps down, John Johnson named interim »

Melinta Therapeutics…

MLNT

Melinta Therapeutics

$3.79

-0.01 (-0.26%)

AVEO

Aveo Pharmaceuticals

$2.50

-0.03 (-1.19%)

PTLA

Portola Pharmaceuticals

$21.92

-0.55 (-2.45%)

SBBP

Strongbridge Biopharma

$4.87

-0.1 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 27

    Nov

  • 31

    Dec

CRBP

Corbus Pharmaceuticals

$7.26

-0.54 (-6.92%)

08:06
10/22/18
10/22
08:06
10/22/18
08:06
Hot Stocks
Corbus data shows 'favorable' safety profiles maintained with Lenabasum »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$106.14

3.455 (3.36%)

08:05
10/22/18
10/22
08:05
10/22/18
08:05
Upgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BSRR

Sierra Bancorp

$26.96

-0.06 (-0.22%)

08:05
10/22/18
10/22
08:05
10/22/18
08:05
Earnings
Sierra Bancorp reports Q3 EPS 46c, consensus 47c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

, GOOGL

Alphabet Class A

$1,104.66

7.43 (0.68%)

08:04
10/22/18
10/22
08:04
10/22/18
08:04
Hot Stocks
Tendril, Google collaborate for energy info for Indiana Michigan Power customers »

Tendril announced a new…

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

GOOGL

Alphabet Class A

$1,104.66

7.43 (0.68%)

AEP

American Electric

$73.25

1.55 (2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 11

    Nov

  • 11

    Nov

  • 03

    Mar

ETTX

Entasis Therapeutics

$7.44

0.34 (4.79%)

08:04
10/22/18
10/22
08:04
10/22/18
08:04
Initiation
Entasis Therapeutics initiated  »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$192.83

-3.91 (-1.99%)

08:04
10/22/18
10/22
08:04
10/22/18
08:04
Hot Stocks
Breaking Hot Stocks news story on Lennox »

Lennox plans $100M of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EIGR

Eiger BioPharmaceuticals

$11.85

-0.18 (-1.50%)

08:04
10/22/18
10/22
08:04
10/22/18
08:04
Hot Stocks
Eiger BioPharmaceuticals' lonafarnib receives RPD designation from FDA »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

LII

Lennox

$192.83

-3.91 (-1.99%)

08:03
10/22/18
10/22
08:03
10/22/18
08:03
Earnings
Lennox cuts FY18 adjusted EPS view to $8.70-$9.10 from $8.90-$9.30 »

FY18 consensus $9.23.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BLMN

Bloomin' Brands

$19.57

-0.11 (-0.56%)

08:03
10/22/18
10/22
08:03
10/22/18
08:03
Hot Stocks
Barington calls on Bloomin' directors to improve board oversight of management »

Barington Capital Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

KLXE

KLX Energy

$32.22

0.27 (0.85%)

08:02
10/22/18
10/22
08:02
10/22/18
08:02
Conference/Events
KLX Energy to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MCD

McDonald's

$167.45

0.61 (0.37%)

08:02
10/22/18
10/22
08:02
10/22/18
08:02
Recommendations
McDonald's analyst commentary  »

McDonald's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HON

Honeywell

$153.49

-1.73 (-1.11%)

08:02
10/22/18
10/22
08:02
10/22/18
08:02
Recommendations
Honeywell analyst commentary  »

Honeywell growth and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AROW

Arrow Financial

$34.92

-0.39 (-1.10%)

08:01
10/22/18
10/22
08:01
10/22/18
08:01
Earnings
Arrow Financial reports Q3 EPS 64c, one estimate 65c »

Reports Q3 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$158.35

2.15 (1.38%)

08:01
10/22/18
10/22
08:01
10/22/18
08:01
Hot Stocks
Accenture agrees to acquire New Content, terms not disclosed »

Accenture has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 13

    Nov

MCRB

Seres Therapeutics

08:01
10/22/18
10/22
08:01
10/22/18
08:01
Initiation
Seres Therapeutics initiated  »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$11.05

-0.425 (-3.71%)

08:00
10/22/18
10/22
08:00
10/22/18
08:00
Recommendations
Cleveland-Cliffs analyst commentary  »

Cleveland-Cliffs dividend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$77.74

-9.33 (-10.72%)

08:00
10/22/18
10/22
08:00
10/22/18
08:00
Recommendations
VF Corp. analyst commentary  »

VF Corp. near-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVAX

Dynavax

$10.90

-0.47 (-4.13%)

08:00
10/22/18
10/22
08:00
10/22/18
08:00
Recommendations
Dynavax analyst commentary  »

Dynavax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.